Artificial organ market seen reaching $41.12 billion by 2030

The Business Research Company says the artificial organ market will grow from $28.36 billion in 2026 to $41.12 billion by 2030, driven by transplant demand, donor shortages and medical advances. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - The artificial organ market is expanding as organ failure cases rise and donor shortages persist. - The growth points to continued demand for devices that can replace, replicate or support failing organs. - The market outlook also signals more investment in bioengineered organs, regenerative medicine and long-term implantable devices.

What happened: - The Business Research Company released its "Artificial Organ Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035" on July 27, 2026. - The report puts the market at $25.73 billion in 2025 and $28.36 billion in 2026. - The report forecasts the market will reach $41.12 billion by 2030. - The report says North America held the largest share of the artificial organ market in 2025. - The report says Asia-Pacific is expected to be the fastest-growing region over the forecast period.

The details: - The 2026 market value implies a 10.2% compound annual growth rate from 2025 to 2026. - The report links recent growth to more organ failure cases, a shortage of donor organs, advances in biomedical engineering, expansion of dialysis and cardiac support therapies, and longer transplant waiting lists. - The forecast through 2030 reflects a 9.7% compound annual growth rate. - Growth drivers in the report include greater investment in bioengineered organs, wider adoption of personalized implant solutions, increased funding for artificial organ research, breakthroughs in regenerative medicine and broader acceptance of long-term implantable devices. - The report highlights rising use of implantable artificial organs, advanced biomaterials, smart and sensor-enabled devices, minimally invasive implantation techniques and stronger focus on long-term biocompatibility. - The company defines an artificial organ as a device implanted or integrated into the human body to replace, replicate or enhance a natural organ's function. - The report says these devices can help patients return to normal activities sooner and improve quality of life and medical outcomes. - The geographic coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, and updated graphics and tables. - The report offers a free sample and full version through links provided by The Business Research Company: Download a free sample and View the full report.

Between the lines: - The strongest demand signal in the report is the gap between transplant need and donor supply. - The surge in waiting lists suggests artificial organs are moving from niche medical devices toward a broader part of transplant and long-term care planning. - The emphasis on sensors, biomaterials and minimally invasive techniques suggests the market is shifting toward more durable and patient-friendly implants.

What's next: - The report expects growth to continue through 2030 as research spending, device adoption and regenerative medicine progress. - The Asia-Pacific region appears positioned to capture more market share if its forecast growth outpaces other regions. - Medical device developers and investors are likely to focus on bioengineered organs, implantable systems and improved biocompatibility as the market develops.